President & CEO, Texas Biomedical Research Institute
President and CEO, Anadys Pharmaceuticals
Chairman, founder, and CEO of SomaLogic
Managing Director, GlobalSmartEnergy
Founder and Managing Partner, Boston Millennia Partners
Dir., Stem Cell & Regeneration Program, Burnham Institute
CEO of Accio Energy
CEO, GE healthymagination
|
|
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches, that ask you to attend a different meeting every day.... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
[Clarification 5/17/13, 2:05 pm. See below.] Right on the same line with the original lede so you don’t waste space on a carriage return…Antibody drugs seemed to be the topic of the week for San Diego’s life sciences community.... Read more »
AnaptysBio says today the U.S. government has asked the San Diego biotech to produce antibodies that counter the deadly effects of ricin and would not require refrigeration, so batches of anti-ricin antibodies could be stored at room temperatures.
Under a contract... Read more »
San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering. Shares of the biopharmaceutical company began trading... Read more »
It’s been almost two years since Paul Grayson was named as CEO of San Diego’s Anaphore—more than enough time for the former Fate Therapeutics CEO to put a new strategy in place.
The company unveiled the first element of its new... Read more »
Carlsbad, CA-based Sorenson Media CEO Peter Csathy tells me he’s left Sorenson to become CEO of Manatt Digital Media Ventures, a venture fund and digital media business created by the Manatt, Phelps & Phillips law firm in Los Angeles.
The venture... Read more »
After President Obama signed the JOBS Act more than a year ago, Ethan Senturia says he studied the provisions for crowdfunding startups under Title III, and came to the conclusion that it would be more trouble than it was worth.
Today... Read more »
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of startups he likes to get involved in, the trend toward... Read more »
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could have made loads of money at... Read more »
Eight seed-stage tech companies were selected late yesterday to be the first class of startups from San Diego to be admitted to the 10-week business technology accelerator program established by Silicon Valley’s Plug and Play Tech Center.
Every company admitted to... Read more »
Not every speech is improved by visual aids. Abraham Lincoln made do without PowerPoint at Gettysburg (though wags have tried to reimagine that), and Franklin Roosevelt’s voice on the radio in 1933 calmed a nation rattled by the Great Depression... Read more »
Amid the hectic pace of earnings releases, we saw a number of partnership agreements and other developments coming out of San Diego’s life sciences community. Here’s my wrap-up.
—Shares of San Diego-based Receptos (NASDAQ: RCPT), a biotech developing new treatments... Read more »
Capas, a private investment firm established in Detroit last year, has acquired E-Learning Mind, a small San Diego ed-tech company that develops learning programs for corporate customers in such areas as sales training, product knowledge, and health and safety procedures.
Financial... Read more »
A big Taiwanese tech company you probably haven’t heard of is starting to make noise in the U.S. Based out of several hubs around the country, it is positioning itself to gain a foothold in the local market for chips used... Read more »
San Diego-based Lumena Pharmaceuticals says today it has raised $23 million in a Series A round that is intended to carry the company through mid-stage trials of its lead drug candidate for treating a rare group of metabolic disorders that cause... Read more »
The three laws of getting a meeting with a VC: 1) If you don’t know somebody who can provide a referral, don’t even try. 2) Start about four months in advance. 3) Once the meeting is on the books, assume that... Read more »
[Corrected 5/6/13, 10:50 am. See below.] San Diego-based Receptos, a biotech developing new treatments for immune disorders, is among 13 IPOs expected to go public this week, according to Renaissance Capital, a financial firm in Greenwich, CT, that specializes... Read more »
Drug development is a tough business. Small companies that dare to try often end up in public train wrecks when they head to Washington to meet the FDA. It’s a shame, a colossal waste, every time a company gets that far... Read more »
President and CEO, Anaphore Inc.
Co-Founder, VP of Technology, Entropic Communications
President and CEO, Regulus Therapeutics
Partner, Latham and Watkins
Assoc. Prof., Dept. of Cell Biology, Scripps Research Institute
Professor of Computer Graphics, UC San Diego
Co-Founder and CEO, Genoptix
CEO of Sapphire Energy
Founder and CEO, Isis Pharmaceuticals
Dean, Division of Biological Sciences, UC San Diego
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
